Apoptosis enzyme-linked immunosorbent assay distinguishes anticancer drugs from toxic chemicals and predicts drug synergism
- 1 March 2003
- journal article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 145 (1) , 89-99
- https://doi.org/10.1016/s0009-2797(02)00241-7
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (CA83508)
This publication has 19 references indexed in Scilit:
- Development of a high throughput in vitro toxicity screen predictive of high acute in vivo toxic potentialToxicology in Vitro, 2001
- Enzyme-linked immunosorbent assay (ELISA) for the specific detection of apoptotic cells and its application to rapid drug screening.Journal of Immunological Methods, 2001
- Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trialsBritish Journal of Cancer, 2001
- In vitro long-term cytotoxicity testing of 27 MEIC chemicals on Hep G2 cells and comparison with acute human toxicity dataToxicology in Vitro, 2001
- Identification of Apoptotic Cells by Formamide-induced DNA Denaturation in Condensed ChromatinJournal of Histochemistry & Cytochemistry, 2001
- Apoptosis and cancer chemotherapyCell and tissue research, 2000
- Apoptosis and cancer drug targetingJournal of Clinical Investigation, 1999
- Relationship of Mitotic Arrest and Apoptosis to Antitumor Effect of PaclitaxelJNCI Journal of the National Cancer Institute, 1996
- Monoclonal Antibody to Single-Stranded DNA Is a Specific and Sensitive Cellular Marker of ApoptosisExperimental Cell Research, 1996
- Pleiotropic drug resistance and survival advantage in leukemic cells with diminished apoptotic responseInternational Journal of Cancer, 1994